2023. Biomarker-Guided Drug Repurposing and Molecular Validation of Angiotensin-2 Receptor Type-1 in Brain Tumor. Precision Medicine Communications. 3, 1 (Jun. 2023), 27–42. DOI:https://doi.org/10.55627/pmc.003.01.0296.